《大行報告》匯豐研究下調和電(00215.HK)目標價至1.54元 評級「持有」
匯豐研究發表報告,和記電訊香港(00215.HK)中期轉虧9,600萬元,當中服務收益按年跌4%及EBITDA跌7%;派發中期息2.28仙,該行認為,公司在等待商業狀況復甦,未來仍有可能進一步派發特別股息。
該行補充,低估了疫情對和電上半年的業務影響,將其今年營業額預測下調3.2%,EBITDA預測下調3.5%,預測全年淨虧損為9,700萬元。目標價相應由1.6元降至1.54元,維持「持有」評級。
匯豐研究表示,和電將能受惠於香港出入境旅遊增加,但目前能見度仍然有限,估計營運環境會改善,但亦關注其建設網絡成本,指和電在提升網絡上投入巨額投資,令成本增加了,網絡升級將為潛在積極催化劑。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.